Patents Assigned to SHANGHAI YINGLI SCIENCE AND TECHNOLOGY CO., LTD
  • Patent number: 8980829
    Abstract: Disclosed are an aryl glycoside compound as represented by formula I or formula I?, a pharmaceutically acceptable salt thereof, optical isomer thereof or a prodrug thereof. The present invention relates to a method of preparing said aryl glycoside compound and the use thereof. The aryl glycoside compound of the present invention has an excellent ability on inhibit SGLT activity, especially SGLT2 activity, and is diabetes-fighting medicine with great potential.
    Type: Grant
    Filed: February 17, 2012
    Date of Patent: March 17, 2015
    Assignees: Shanghai Yingli Science and Technology Co., Ltd, Shanghai Chempartner Co., Ltd
    Inventors: Zusheng Xu, Su Qian
  • Publication number: 20130324464
    Abstract: Disclosed are an aryl glycoside compound as represented by formula I or formular I?, a pharmaceutically acceptable salt thereof, optical isomer thereof or a prodrug thereof. The present invention relates to a method of preparing said aryl glycoside compound and the use thereof The aryl glycoside compound of the present invention has an excellent ability on inhibit SGLT activity, especially SGLT2 activity, and is diabetes-fighting medicine with great potential.
    Type: Application
    Filed: February 17, 2012
    Publication date: December 5, 2013
    Applicants: SHANGHAI CHEMPARTNER CO., LTD, SHANGHAI YINGLI SCIENCE AND TECHNOLOGY CO., LTD
    Inventors: Zusheng Xu, Su Qian